A selective Cullin 3 RING E3 ligase inhibitor attenuates hyperglycemia via dual insulin sensitizing and insulinotropic action

Key Points

• Hyperglycemia decreases significantly due to selective inhibition of Cul3, enhancing insulin response.
• Cul3 inhibition leads to both insulin sensitization and secretion effects, crucial for regulating blood sugar levels.
• Analysis of the effects shows that cullin pan neddylation inhibitors can effectively target hyperglycemia mechanisms.
• Further understanding is needed for clinical application, particularly regarding long-term effects.

Abstract